Dynamic Technology Lab Private Ltd Grows Stake in Select Medical Holdings Corporation $SEM

Dynamic Technology Lab Private Ltd lifted its position in shares of Select Medical Holdings Corporation (NYSE:SEM) by 441.0% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 58,901 shares of the health services provider’s stock after buying an additional 48,013 shares during the quarter. Dynamic Technology Lab Private Ltd’s holdings in Select Medical were worth $757,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Quantbot Technologies LP purchased a new stake in Select Medical in the 3rd quarter valued at approximately $27,000. MAI Capital Management lifted its holdings in shares of Select Medical by 48,000.0% during the 2nd quarter. MAI Capital Management now owns 2,405 shares of the health services provider’s stock worth $37,000 after acquiring an additional 2,400 shares during the period. Cornerstone Planning Group LLC grew its stake in shares of Select Medical by 6,868.4% during the third quarter. Cornerstone Planning Group LLC now owns 3,972 shares of the health services provider’s stock valued at $51,000 after acquiring an additional 3,915 shares in the last quarter. Wilmington Savings Fund Society FSB boosted its holdings in Select Medical by 20.9% in the third quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock valued at $74,000 after purchasing an additional 999 shares during the last quarter. Finally, Advisors Asset Management Inc. grew its position in shares of Select Medical by 13.2% during the 2nd quarter. Advisors Asset Management Inc. now owns 7,135 shares of the health services provider’s stock valued at $108,000 after buying an additional 834 shares during the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Stock Down 0.0%

Shares of Select Medical stock opened at $16.25 on Tuesday. Select Medical Holdings Corporation has a 1 year low of $11.65 and a 1 year high of $18.60. The company has a market cap of $2.01 billion, a P/E ratio of 14.13, a P/E/G ratio of 0.93 and a beta of 1.22. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.89. The stock has a 50-day moving average price of $15.42 and a 200 day moving average price of $14.32.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, February 19th. The health services provider reported $0.16 earnings per share for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.07). The business had revenue of $1.40 billion during the quarter, compared to analyst estimates of $1.36 billion. Select Medical had a net margin of 2.68% and a return on equity of 7.26%. Select Medical’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.18 EPS. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. As a group, analysts expect that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.

Select Medical declared that its board has authorized a share buyback program on Thursday, February 19th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the health services provider to purchase up to 49.5% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s management believes its stock is undervalued.

Select Medical Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, March 12th. Shareholders of record on Monday, March 2nd will be given a $0.0625 dividend. The ex-dividend date is Monday, March 2nd. This represents a $0.25 dividend on an annualized basis and a yield of 1.5%. Select Medical’s dividend payout ratio is presently 21.74%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on SEM shares. Weiss Ratings upgraded Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, February 20th. Wall Street Zen lowered shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $16.50 target price (down from $19.00) on shares of Select Medical in a research note on Tuesday, March 3rd. Benchmark cut shares of Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. Finally, Zacks Research cut Select Medical from a “hold” rating to a “strong sell” rating in a research note on Thursday, February 26th. Two investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $15.63.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.